Cardiovascular Disease Risk Assessment
- 1 Basic Facts
- 2 Brief overview of the measure
- 3 Application and interpretation of the measure
- 4 Calculation of the measure
- 5 Appraisal of the measure
- 6 Other items
- 7 Owner details
Stage of development
Potential or current usage
This measure has been part of the PHO Performance Programme's National Indicator Set since 1 July 2008 and is used to determine what proportion of the population eligible for a CVD risk assessment have had their risk recorded in the past 5 years.
Brief overview of the measure
This measure focuses on what proportion of the population eligible for a CVD risk assessment have had their risk recorded in the past 5 years.
Rationale for selection
A Cardiovascular Risk Assessment (CVRA) is a tool for identifying individuals at high risk of a cardiovascular event (e.g. stroke, heart attack or angina) and enables health carers to provide appropriate patient management and support. Cardiovascular disease (CVD) is the leading cause of death in New Zealand - preventative treatment can increase life expectancy and quality of life for patients at risk of CVD.
Domain(s) of qualitY
Application and interpretation of the measure
Stated intent of the measure
Ensuring people who are at risk of having cardiovascular disease are identified so that appropriate interventions can be introduced.
Level of health care delivery/setting
This measure is currently reported by the PHO Performance Programme to PHO level although use of this measure to monitor practice and patient level performance is also possible.
Males of Māori, Pacific or Indian sub-continent ethnicity aged 35 to 74 years Females of Māori, Pacific or Indian sub-continent ethnicity aged 45 to 74 years Males of any other ethnicity aged 45 to 74 years Females of any other ethnicity aged 55 to 74 years
Stratification by vulnerable populations
The PHO Performance Programme currently uses this measure to monitor at both a total PHO enrolled population level (all PHO enrolled eligible patients) and a high need PHO enrolled population level (whereby high need is identified as Māori, Pacific Island and/or Decile 9 or 10)
This measure is currently funded through the PHO Performance Programme both at a total population level and a high need level.
Calculation of the measure
Output of calculation
Percentage of elgible patients enrolled in a PHO that have had a CVD risk assessment in the past 5 years.
Number of enrolled people within the eligible population who have had a CVD risk recorded in the past 5 years.
Number of enrolled people in the PHO who are eligible for a CVD risk assessment.
Criteria/standard for optimal performance
Every practice within a PHO should have a process in place for assessing CVD risk for eligible patients. The PHO Performance Programme goal (to be achieved over a 5 year period) is: 80% or more of a PHO’s target population have been assessed for their risk of developing cardiovascular disease.
PHO Clinical Performance Indicator Report and PHO patient enrolment registers.
Method of extraction
The link below will take you to the document that defines how the measure is calculated - see 'CVD Risk Assessment' section of the Indicator Definitions for PHOs document. (http://www.dhbnz.org.nz/Site/SIG/pho/Operational-Documents.aspx )
Appraisal of the measure
This measure was developed by the PHO Performance Programme (which consists of an Advisory Group (refer to following link for current membership list: http://www.dhbnz.org.nz/Site/SIG/pho/PHO/Membership-List.aspx), a Governance Group (refer to following link for current membership list: http://www.dhbnz.org.nz/Site/SIG/pho/PHO/Governance-Group-Membership-List.aspx), and support team.
Date of entry to library
Owner (Organisation name)
PHO Performance Programme
Owner (Email contact)
Creator (Organisation name)
PHO Performance Programme
Creator (Email contact)